|
Children’s Hospital of Philadelphia Becomes First Accredited Pediatric Heart …
eReleases (press release) “The heart failure program at The Children’s Hospital of Philadelphia is enthusiastic about working with the Colloquium,” said Dr. Joseph Rossano, Medical Director of Heart Transplantation. “Working together with other Children’s Hospitals throughout … |
Children's Hospital of Philadelphia Becomes First Accredited Pediatric Heart … – PR Newswire (press release)
|
Children’s Hospital of Philadelphia Becomes First Accredited Pediatric Heart …
PR Newswire (press release) 16, 2013 /PRNewswire/ — The Healthcare Accreditation Colloquium announced today that Children’s Hospital of Philadelphia (CHOP) became the first Accredited Pediatric Heart Failure Institute in Pennsylvania and third in the nation following nearly a … |
Fc Protein and Glycoengineered Antibodies Market, 2013 – 2023 – MarketWatch (press release)
Fc Protein and Glycoengineered Antibodies Market, 2013 – 2023MarketWatch (press release)Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from both large and small pharmaceutical companies. Developed through …
Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas – 24/7 Wall St.
Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas24/7 Wall St.Biogen also is partnering with AbbVie Inc. (NYSE: ABBV) in Phase III trials for Daclizumab. Credit Suisse has a $255 dollar price target on this top name. The consen…
Cancer drug has potential to treat diabetes – Times of India
Times of IndiaCancer drug has potential to treat diabetesTimes of IndiaThe studies, done in mice, identify a previously unexpected link between a low-oxygen condition called hypoxia and the ability of cells in the liver to respond to insulin. The drug,…
UNITEDHEALTH GROUP INC. : Collaborations, New Studies, and New Drug … – 4-traders (press release)
UNITEDHEALTH GROUP INC. : Collaborations, New Studies, and New Drug …4-traders (press release)Gilead also informed that along with this NDA, the Company submitted data that supports the use of idelalisib for patients with iNHL that is refractory (non…
Parents' plea for donors to help youngster Ailsa who has life-threatening … – Scottish Daily Record
Scottish Daily Record |
Parents’ plea for donors to help youngster Ailsa who has life-threatening …
Scottish Daily Record After suffering the heartbreak of a failed stem cell transplant, mum Kirsteen and dad Neil are making a plea to Scots for help. They want people to sign up to stem cell and bone marrow registries in the hope of finding a match. Neil, 41, said: “That … |
Alves offered to donate liver to Abidal – Times of India
Goal.com IndiaAlves offered to donate liver to AbidalTimes of IndiaAbidal was first diagnosed with a tumour on his liver in March 2011 and after briefly returning to the first team, was ruled out of the game for over a year to undergo the transplant in…
Gallacher on the mend after heart scare – Times of India
Mirror.co.uk |
Gallacher on the mend after heart scare
Times of India Former Ryder Cup player and captain Bernard Gallacher has said he expects to make a full recovery from serious heart problems. The 64-year-old … The Daily Mail reported that medics restarted his heart three times following a cardiac arrest. Gallacher … Golf legend Bernard Gallacher’s heart ‘stopped three times’ in near-death episodeDaily News & Analysis |
Zydus Launches India's First NCE "Lipaglyn" – RTT News
|
Zydus Launches India’s First NCE “Lipaglyn”
RTT News Wit a non-renal route of elimination, Lipaglyn has no adverse events like edema, weight gain, myopathies or derangement of liver and/or kidney functions, thus making it safe and efficacious. Lipaglyn is recommended for once daily administration as a 4 … |